Tiam1/Rac1 signals contribute to CLL cell proliferation and chemoresistance
Hofbauer, SW, Krenn, PW, Ganghammer, S, Asslaber, D, Pichler, U, Wallner, M, Henschler, R, Greil, R, Hartmann, TN ONKOLOGIE. 2013, 36: 56-56.
CXCR3 modulates CXCL12-mediated cellular responses in chronic lymphocytic leukemia
Ganghammer, S, Hinterseer, E, Johrer, K, Greil, R, Hartmann, TN CYTOKINE. 2013, 63(3): 264-264.
Antiapoptotic effects of p21 regarding its subcellular localization in arsenic trioxide induced apoptosis in CLL
Sifft, E, Hofbauer, JP, Asslaber, D, Hartmann, TN, Merkel, O, Greil, R ONKOLOGIE. 2013, 36: 222-222.
Mimicking the microenvironment in chronic lymphocytic leukaemia – where does the journey go?
Asslaber D, GrГ¶ssinger EM, Girbl T, Hofbauer SW, Egle A, Weiss L, Greil R, Hartmann TN. Br J Haematol. 2013 Mar,160(5):711-4. doi: 10.1111/bjh.12151. Epub 2012 Dec 4.
View this publication in the PUBMED databaseThe transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival
Asslaber, D, Hofbauer, JP, Zaborsky, N, Kocher, T, Hartmann, TN, Greil, R, Egle, A ONKOLOGIE. 2013, 36: 222-223.
Blockade of the Potassium Channel KCa3.1 inhibits proliferation in Chronic Lymphocytic Leukemia
Grossinger, EM, Weiss, L, Zierler, S, Hinterseer, E, Schmolzer, J, Asslaber, D, Hainzl, S, Egle, A, Pinon, JD, Hartmann, TN, Greil, R, Kerschbaum, HH ONKOLOGIE. 2013, 36: 191-192.
A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients.
Hufnagl C, StГ¶cher M, Moik M, Geisberger R, Greil R. Journal of Nucleic Acids Investigation. 2013. DOI: 10.4081/jnai.2013.e1
Dendritic Cells Activated by IFN-?/STAT1 Express IL-31 Receptor and Release Proinflammatory Mediators upon IL-31 Treatment.
Horejs-Hoeck J, Schwarz H, Lamprecht S, Maier E, Hainzl S, Schmittner M, Posselt G, Stoecklinger A, Hawranek T, Duschl A. J Immunol. 2012 Jun 1,188(11):5319-26. doi: 10.4049/jimmunol.1101044. Epub 2012 Apr 25.
View this publication in the PUBMED databasePDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.
Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, Merkel O, Schiefer AI, Hassler MR, Heider S, Amenitsch L, Thallinger C, Staber PB, Simonitsch-Klupp I, Artaker M, Lagger S, Turner SD, Pileri S, Piccaluga PP, Valent P, Messana K, Landra I, Weichhart T, Knapp S, Shehata M, Todaro M, Sexl V, HГ¶fler G, Piva R, Medico E, Ruggeri BA, Cheng M, Eferl R, Egger G, Penninger JM, Jaeger U, Moriggl R, Inghirami G, Kenner L. Nat Med. 2012 Nov,18(11):1699-704. doi: 10.1038/nm.2966. Epub 2012 Oct 14.
View this publication in the PUBMED databaseUpgraded Cobas TaqMan version 2: hidden consequences at cohort level
Taylor, N, Grabmeier-Pfistershammer, K, Oberkofler, H, Egle, A, Rieger, A, Ledergerber, B J INT AIDS SOC. 2012, 15: 109-109.